Streuer, Alexander
Jann, Johann-Christoph
Boch, Tobias
Mossner, Maximilian
Riabov, Vladimir
Schmitt, Nanni
Altrock, Eva
Xu, Qingyu
Demmerle, Marie
Nowak, Verena
Oblaender, Julia
Palme, Iris
Weimer, Nadine
Rapp, Felicitas
Metzgeroth, Georgia
Hecht, Anna
Höger, Thomas
Merz, Christian
Hofmann, Wolf-Karsten
Nolte, Florian
Nowak, Daniel
Funding for this research was provided by:
ICON clinican scientist program at the medical faculty Mannheim of Heidelberg University
Health + Life Science Alliance Heidelberg Mannheim
China Scholarship Council
Apogenix GmbH, Heidelberg
H.W. & J. Hector Foundation (Project M83)
Deutsche Forschungsgemeinschaft (No. 817/5–2, FOR2033, NICHEM)
Forum Gesundheitsstandort Baden‑Württemberg, Projektvorhaben „Identifizierung und Nutzung molekularer und biologischer Muster für die individuelle Krebsbehandlung" (BW 4‑5400/136/1)
German cancer aid foundation (70113953)
Gutermuth Foundation
Wilhelm Sander Foundation (2020.089.1)
Werner-Jackstaedt-foundation
German José‑Carreras‑Foundation (DJCLSH03/01)
Medizinische Fakultät Mannheim der Universität Heidelberg
Article History
Received: 19 December 2023
Accepted: 14 February 2024
First Online: 27 February 2024
Declarations
:
: T.H. and C.M. are employees of Apogenix AG, F.N. has received honoraria and research funding from Apogenix AG, T.B. received a travel grant from Apogenix AG. D.N. has received research funding from Apogenix AG. F.N. and W.-K.H. have received honoraria from Apogenix AG. W.-K.H. is also member of the editorial board of Annals of hematology.All other authors have no conflicts of interest to declare.